| Phase 13 trials |
|
Phase 1
|
NCT05558124 |
Feb 2023 → Apr 2027 expected |
acute myeloid leukemia |
H. Lee Moffitt Cancer Center and Research Institute |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT05024552 |
Feb 2022 → Feb 2027 expected |
acute myeloid leukemia, FLT3 internal tandem duplication |
H. Lee Moffitt Cancer Center and Research Institute |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT03826992 |
Dec 2018 → Jan 2027 expected |
leukemia |
Children's Hospital Medical Center, Cincinnati |
Recruiting
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT04049539 |
Jan 2021 → Dec 2026 expected |
acute myeloid leukemia |
Ohio State University Comprehensive Cancer Center |
Recruiting
|
No outcome recorded
|
| Phase 22 trials |
|
Phase 2
|
NCT05599360 |
Aug 2022 → Sep 2028 expected |
acute myeloid leukemia |
Shaare Zedek Medical Center |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04425655 |
Aug 2020 → Jul 2022 |
acute myeloid leukemia |
University of California, San Diego |
Terminated
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT04217278 |
Jan 2020 → May 2026 overdue |
acute myeloid leukemia, myelodysplastic syndrome |
University of Birmingham |
Active not recruiting
|
No outcome recorded
|